Merck's experimental pill enlicitide sharply lowered cholesterol in a large study - Top-Institutions - MDSpire

Merck's experimental pill enlicitide sharply lowered cholesterol in a large study

  • By

  • Lauran Neergaard

  • February 4, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    UT Southwestern Medical Center
    UT Southwestern Medical Center

    Dallas, TX

    Key Differentiators

    • Cardiology
    • Lipidology
    • Clinical Trials

  • #2

    Brigham and Women's Hospital
    Brigham and Women's Hospital

    Boston, MA

    Key Differentiators

    • Cardiology
    • Preventive Medicine
    • Clinical Research

  • #3

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Cardiology
    • Lipidology
    • Clinical Trials

  • #4

    Johns Hopkins Medicine
    Johns Hopkins Medicine

    Baltimore, MD

    Key Differentiators

    • Cardiology
    • Lipidology
    • Translational Research

  • #5

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Cardiology
    • Clinical Trials
    • Preventive Cardiology

Original Source(s)

Merck's experimental pill enlicitide sharply lowered cholesterol in a large study

  • by Lauran Neergaard

  • February 4, 2026

Related Content

Could gene editing offer the one-time fix for artery-clogging cholesterol?

Enhanced transseptal puncture technique utilizing modified intracardiac echocardiography and ablation catheter guidance

NPs Top US Jobs List Again

The nurse practitioner profession claims the No. 1 spot across three categories in the U.S. News & World Report 2026 Best Jobs rankings for the third consecutive year.